Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert A Hauser

Showing results (1-10 of 266) with videos related to

Pageof 27
Sort By:
European Neurology|May 2, 2009
Levodopa: past, present, and futureRobert A Hauser
Expert Review of Neurotherapeutics|February 1, 2012
IPX066: a novel carbidopa-levodopa extended-release formulationRobert A Hauser
The Lancet. Neurology|June 4, 2013
PROUD stands tall: delayed-start studies in Parkinson's diseaseRobert A Hauser
The Lancet. Neurology|June 28, 2015
α-Synuclein in Parkinson's disease: getting to the core of the matterRobert A Hauser
Neurology|January 14, 2004
Levodopa/carbidopa/entacapone (Stalevo)Robert A Hauser
Parkinsonism & Related Disorders|January 20, 2010
New considerations in the medical management of early Parkinson's disease: impact of recent clinical trials on treatment strategyRobert A Hauser
The International Journal of Neuroscience|November 1, 2011
Future treatments for Parkinson's disease: surfing the PD pipelineRobert A Hauser
NPJ Parkinson'S Disease|October 3, 2018
Help cure Parkinson's disease: please don't waste the Golden YearRobert A Hauser
The American Journal of Managed Care|March 20, 2010
Early pharmacologic treatment in Parkinson's diseaseRobert A Hauser
Geriatrics|September 23, 2006
Long-term care of Parkinson's disease. Strategies for managing "wearing off" symptom re-emergence and dyskinesiasRobert A Hauser
Pageof 27

Showing results (1-10 of 266) with videos related to

Sort By:
Pageof 27
European Neurology|May 2, 2009
Levodopa: past, present, and futureRobert A Hauser
Expert Review of Neurotherapeutics|February 1, 2012
IPX066: a novel carbidopa-levodopa extended-release formulationRobert A Hauser
The Lancet. Neurology|June 4, 2013
PROUD stands tall: delayed-start studies in Parkinson's diseaseRobert A Hauser
The Lancet. Neurology|June 28, 2015
α-Synuclein in Parkinson's disease: getting to the core of the matterRobert A Hauser
Neurology|January 14, 2004
Levodopa/carbidopa/entacapone (Stalevo)Robert A Hauser
Parkinsonism & Related Disorders|January 20, 2010
New considerations in the medical management of early Parkinson's disease: impact of recent clinical trials on treatment strategyRobert A Hauser
The International Journal of Neuroscience|November 1, 2011
Future treatments for Parkinson's disease: surfing the PD pipelineRobert A Hauser
NPJ Parkinson'S Disease|October 3, 2018
Help cure Parkinson's disease: please don't waste the Golden YearRobert A Hauser
The American Journal of Managed Care|March 20, 2010
Early pharmacologic treatment in Parkinson's diseaseRobert A Hauser
Geriatrics|September 23, 2006
Long-term care of Parkinson's disease. Strategies for managing "wearing off" symptom re-emergence and dyskinesiasRobert A Hauser
Pageof 27